nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Common cold—Lisinopril—dilated cardiomyopathy	0.0759	0.0761	CcSEcCtD
Gallamine Triethiodide—Eruption—Furosemide—dilated cardiomyopathy	0.0429	0.043	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.0301	0.0302	CcSEcCtD
Gallamine Triethiodide—Bone marrow depression—Lisinopril—dilated cardiomyopathy	0.0293	0.0294	CcSEcCtD
Gallamine Triethiodide—Throat sore—Lisinopril—dilated cardiomyopathy	0.0275	0.0275	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0272	0.0273	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Lisinopril—dilated cardiomyopathy	0.0239	0.024	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0218	0.0218	CcSEcCtD
Gallamine Triethiodide—Swelling—Furosemide—dilated cardiomyopathy	0.0217	0.0218	CcSEcCtD
Gallamine Triethiodide—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0192	0.0193	CcSEcCtD
Gallamine Triethiodide—Malaise—Spironolactone—dilated cardiomyopathy	0.0191	0.0192	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Spironolactone—dilated cardiomyopathy	0.019	0.019	CcSEcCtD
Gallamine Triethiodide—Confusional state—Spironolactone—dilated cardiomyopathy	0.0175	0.0175	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.0169	0.017	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Furosemide—dilated cardiomyopathy	0.0164	0.0164	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.0149	0.015	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0143	0.0143	CcSEcCtD
Gallamine Triethiodide—Urticaria—Spironolactone—dilated cardiomyopathy	0.0137	0.0138	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0137	0.0137	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.0129	0.0129	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0128	0.0128	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Furosemide—dilated cardiomyopathy	0.0124	0.0124	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.0123	0.0123	CcSEcCtD
Gallamine Triethiodide—Pruritus—Spironolactone—dilated cardiomyopathy	0.0122	0.0123	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0118	0.0119	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0118	0.0118	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0113	0.0113	CcSEcCtD
Gallamine Triethiodide—Vomiting—Spironolactone—dilated cardiomyopathy	0.011	0.011	CcSEcCtD
Gallamine Triethiodide—Rash—Spironolactone—dilated cardiomyopathy	0.0109	0.0109	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0109	0.0109	CcSEcCtD
Gallamine Triethiodide—Headache—Spironolactone—dilated cardiomyopathy	0.0108	0.0109	CcSEcCtD
Gallamine Triethiodide—Anaemia—Furosemide—dilated cardiomyopathy	0.0107	0.0107	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Furosemide—dilated cardiomyopathy	0.0103	0.0104	CcSEcCtD
Gallamine Triethiodide—Nausea—Spironolactone—dilated cardiomyopathy	0.0103	0.0103	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00997	0.01	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00975	0.00978	CcSEcCtD
Gallamine Triethiodide—Confusional state—Furosemide—dilated cardiomyopathy	0.00949	0.00952	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00922	0.00925	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Furosemide—dilated cardiomyopathy	0.00915	0.00917	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00848	0.0085	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00845	0.00848	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00813	0.00815	CcSEcCtD
Gallamine Triethiodide—Fatigue—Furosemide—dilated cardiomyopathy	0.00812	0.00814	CcSEcCtD
Gallamine Triethiodide—Pain—Furosemide—dilated cardiomyopathy	0.00805	0.00807	CcSEcCtD
Gallamine Triethiodide—Anaemia—Lisinopril—dilated cardiomyopathy	0.008	0.00802	CcSEcCtD
Gallamine Triethiodide—Angioedema—Lisinopril—dilated cardiomyopathy	0.00791	0.00793	CcSEcCtD
Gallamine Triethiodide—Malaise—Lisinopril—dilated cardiomyopathy	0.00781	0.00783	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00776	0.00778	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00775	0.00777	CcSEcCtD
Gallamine Triethiodide—Cough—Lisinopril—dilated cardiomyopathy	0.00755	0.00758	CcSEcCtD
Gallamine Triethiodide—Urticaria—Furosemide—dilated cardiomyopathy	0.00748	0.0075	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00744	0.00746	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00744	0.00746	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00737	0.00739	CcSEcCtD
Gallamine Triethiodide—Chest pain—Lisinopril—dilated cardiomyopathy	0.00737	0.00739	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00732	0.00734	CcSEcCtD
Gallamine Triethiodide—Confusional state—Lisinopril—dilated cardiomyopathy	0.00712	0.00714	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00694	0.00696	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00692	0.00694	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0069	0.00691	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00686	0.00688	CcSEcCtD
Gallamine Triethiodide—Asthenia—Furosemide—dilated cardiomyopathy	0.00676	0.00677	CcSEcCtD
Gallamine Triethiodide—Pruritus—Furosemide—dilated cardiomyopathy	0.00666	0.00668	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00644	0.00646	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00644	0.00645	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00634	0.00636	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0061	0.00612	CcSEcCtD
Gallamine Triethiodide—Fatigue—Lisinopril—dilated cardiomyopathy	0.00609	0.00611	CcSEcCtD
Gallamine Triethiodide—Pain—Lisinopril—dilated cardiomyopathy	0.00604	0.00606	CcSEcCtD
Gallamine Triethiodide—Vomiting—Furosemide—dilated cardiomyopathy	0.00599	0.006	CcSEcCtD
Gallamine Triethiodide—Rash—Furosemide—dilated cardiomyopathy	0.00594	0.00595	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Furosemide—dilated cardiomyopathy	0.00593	0.00595	CcSEcCtD
Gallamine Triethiodide—Headache—Furosemide—dilated cardiomyopathy	0.0059	0.00592	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00582	0.00584	CcSEcCtD
Gallamine Triethiodide—Urticaria—Lisinopril—dilated cardiomyopathy	0.00561	0.00563	CcSEcCtD
Gallamine Triethiodide—Nausea—Furosemide—dilated cardiomyopathy	0.00559	0.00561	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00558	0.0056	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00558	0.0056	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00521	0.00522	CcSEcCtD
Gallamine Triethiodide—Asthenia—Lisinopril—dilated cardiomyopathy	0.00507	0.00508	CcSEcCtD
Gallamine Triethiodide—Pruritus—Lisinopril—dilated cardiomyopathy	0.005	0.00501	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00483	0.00485	CcSEcCtD
Gallamine Triethiodide—Vomiting—Lisinopril—dilated cardiomyopathy	0.00449	0.0045	CcSEcCtD
Gallamine Triethiodide—Rash—Lisinopril—dilated cardiomyopathy	0.00445	0.00447	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00445	0.00446	CcSEcCtD
Gallamine Triethiodide—Headache—Lisinopril—dilated cardiomyopathy	0.00443	0.00444	CcSEcCtD
Gallamine Triethiodide—Nausea—Lisinopril—dilated cardiomyopathy	0.0042	0.00421	CcSEcCtD
Gallamine Triethiodide—ACHE—Glycerophospholipid biosynthesis—TAZ—dilated cardiomyopathy	0.000159	0.0566	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000138	0.0493	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.000116	0.0414	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Phospholipid metabolism—TAZ—dilated cardiomyopathy	0.000111	0.0395	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	8.74e-05	0.0312	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	8.47e-05	0.0302	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—AGT—dilated cardiomyopathy	7.68e-05	0.0274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	7.26e-05	0.0258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	7.12e-05	0.0254	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—ABCC9—dilated cardiomyopathy	6.99e-05	0.0249	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	6.86e-05	0.0245	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—ACTN2—dilated cardiomyopathy	6.7e-05	0.0239	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.3e-05	0.0224	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	5.77e-05	0.0206	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—ACE—dilated cardiomyopathy	5.55e-05	0.0198	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	5.41e-05	0.0193	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	5.36e-05	0.0191	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	5.22e-05	0.0186	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	5.17e-05	0.0184	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	4.32e-05	0.0154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—ABCC9—dilated cardiomyopathy	4.32e-05	0.0154	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—ACTN2—dilated cardiomyopathy	4.14e-05	0.0148	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	3.95e-05	0.0141	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	3.89e-05	0.0138	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.79e-05	0.0135	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.57e-05	0.0127	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Peptide hormone metabolism—AGT—dilated cardiomyopathy	3.52e-05	0.0125	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Monoamine Transport—TNF—dilated cardiomyopathy	3.48e-05	0.0124	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	3.08e-05	0.011	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—TAZ—dilated cardiomyopathy	3.08e-05	0.011	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	3.05e-05	0.0109	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	2.65e-05	0.00943	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	2.54e-05	0.00904	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	2.09e-05	0.00746	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	2.06e-05	0.00732	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.04e-05	0.00726	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	2.02e-05	0.00719	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.99e-05	0.00709	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	1.96e-05	0.007	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	1.96e-05	0.00697	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	1.96e-05	0.00697	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	1.93e-05	0.00686	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	1.82e-05	0.00648	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.82e-05	0.00647	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	1.75e-05	0.00623	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—ANKRD1—dilated cardiomyopathy	1.69e-05	0.00602	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	1.69e-05	0.00601	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	1.63e-05	0.00583	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	1.6e-05	0.00568	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—TAZ—dilated cardiomyopathy	1.59e-05	0.00566	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	1.56e-05	0.00554	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	1.56e-05	0.00554	CbGpPWpGaD
Gallamine Triethiodide—CHRNA2—Neuronal System—RAF1—dilated cardiomyopathy	1.52e-05	0.00543	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	1.45e-05	0.00515	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—SDHA—dilated cardiomyopathy	1.44e-05	0.00512	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	1.4e-05	0.00499	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	1.4e-05	0.00497	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	1.32e-05	0.00472	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.28e-05	0.00455	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	1.23e-05	0.00438	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—LMNA—dilated cardiomyopathy	1.21e-05	0.00432	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	1.2e-05	0.00426	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	1.18e-05	0.00422	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	1.18e-05	0.00422	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	1.13e-05	0.00404	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	1.1e-05	0.00392	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	1.07e-05	0.0038	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	1.06e-05	0.00377	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	1.06e-05	0.00377	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—ACE—dilated cardiomyopathy	1.05e-05	0.00373	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Neuronal System—RAF1—dilated cardiomyopathy	9.43e-06	0.00336	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.11e-06	0.00325	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.76e-06	0.00312	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.76e-06	0.00312	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	8.64e-06	0.00308	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.53e-06	0.00304	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.42e-06	0.003	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.34e-06	0.00297	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.68e-06	0.00274	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	7.26e-06	0.00258	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	6.7e-06	0.00239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	6.7e-06	0.00239	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.66e-06	0.00237	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism of proteins—AGT—dilated cardiomyopathy	6.64e-06	0.00237	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	6.41e-06	0.00228	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.22e-06	0.00222	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.08e-06	0.00217	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.08e-06	0.00217	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.03e-06	0.00215	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.65e-06	0.00201	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.47e-06	0.00195	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.15e-06	0.00183	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	4.88e-06	0.00174	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.68e-06	0.00167	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.44e-06	0.00158	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.05e-06	0.00144	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—GPX1—dilated cardiomyopathy	3.9e-06	0.00139	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—CD36—dilated cardiomyopathy	3.8e-06	0.00135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	3.79e-06	0.00135	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.62e-06	0.00129	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.59e-06	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.59e-06	0.00128	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.44e-06	0.00123	CbGpPWpGaD
Gallamine Triethiodide—ACHE—Metabolism—AGT—dilated cardiomyopathy	3.42e-06	0.00122	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.34e-06	0.00119	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.29e-06	0.00117	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.23e-06	0.00115	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.76e-06	0.000984	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.62e-06	0.000934	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.28e-06	0.000813	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.25e-06	0.000802	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.03e-06	0.000725	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	1.94e-06	0.000692	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.57e-06	0.000558	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.35e-06	0.000481	CbGpPWpGaD
Gallamine Triethiodide—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.25e-07	0.00033	CbGpPWpGaD
